DNA-based vaccine with genes coding for two HIV proteins: Began a Phase I/II trial of safety in 15 people who will receive an initial injection at one of three

Apollon Inc., Malvern, Penn.
Product: DNA-based vaccine

Read the full 72 word article

How to gain access

Continue reading with a
two-week free trial.